A detailed history of Fmr LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,237,904 shares of HRMY stock, worth $183 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,237,904
Previous 5,255,518 0.34%
Holding current value
$183 Million
Previous $176 Million 10.46%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$28.81 - $33.01 $507,459 - $581,438
-17,614 Reduced 0.34%
5,237,904 $158 Million
Q1 2024

May 13, 2024

SELL
$29.93 - $35.06 $637,718 - $747,023
-21,307 Reduced 0.4%
5,255,518 $176 Million
Q4 2023

Feb 13, 2024

SELL
$19.2 - $33.78 $3.33 Million - $5.86 Million
-173,384 Reduced 3.18%
5,276,825 $170 Million
Q3 2023

Nov 13, 2023

SELL
$31.89 - $39.03 $639,011 - $782,083
-20,038 Reduced 0.37%
5,450,209 $179 Million
Q2 2023

Aug 11, 2023

SELL
$30.5 - $37.4 $3.7 Million - $4.54 Million
-121,328 Reduced 2.17%
5,470,247 $192 Million
Q1 2023

May 11, 2023

BUY
$30.8 - $53.92 $272,487 - $477,030
8,847 Added 0.16%
5,591,575 $183 Million
Q4 2022

Feb 13, 2023

SELL
$45.4 - $60.91 $1.48 Million - $1.99 Million
-32,611 Reduced 0.58%
5,582,728 $308 Million
Q3 2022

Nov 10, 2022

BUY
$42.06 - $55.45 $7.93 Million - $10.5 Million
188,557 Added 3.47%
5,615,339 $249 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $17.8 Million - $27.6 Million
529,600 Added 10.81%
5,426,782 $265 Million
Q1 2022

May 13, 2022

BUY
$33.14 - $51.13 $22.9 Million - $35.3 Million
689,583 Added 16.39%
4,897,182 $238 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $2.68 Million - $3.45 Million
78,648 Added 1.9%
4,207,599 $179 Million
Q3 2021

Nov 15, 2021

SELL
$25.68 - $38.61 $20.9 Million - $31.4 Million
-812,576 Reduced 16.44%
4,128,951 $158 Million
Q2 2021

Aug 13, 2021

BUY
$25.96 - $33.44 $128 Million - $165 Million
4,941,527 New
4,941,527 $139 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.07B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.